Infrequent IV infusions of zoledronate significantly reduce fracture risks in postmenopausal women, according to a decade-long study. Women receiving two doses within five years had a 44 per cent ...
Study authors Susan D. Reed, MD, MPH, MS, and Erin Dwyer, MPH, both at the University of Washington School of Medicine, attribute some of these different challenges to underlying health disparities.